BFSG, LLC

SEC CIK: 0001706836
Latest filing: Jul 20, 2026

SEC filings (opens in a new tab)

RVNC holding history

Revance Therapeutics, Inc. in every 13F filed by BFSG, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RVNC overview All 13F holders of RVNC Full Q2 2026 holdings

Shares (Q2 2023): 0; Sold out in Q2 2023
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q4 2022

Holdings of RVNC by BFSG, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2023	0	$0	0.0%	−23,699−100.0%	Sold out	Holders
Q1 2023	23,699	$763.0K	0.1%	−44,094−65.0%	Reduced	Holders
Q4 2022	67,793	$1.25M	0.3%	+67,793	New	Holders